{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:31:54Z","timestamp":1790839914604,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.nmd.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T01:58:29Z","timestamp":1680919109000},"page":"447-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7291-5408","authenticated-orcid":false,"given":"Federica","family":"Montagnese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"de Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.L.F.","family":"Lemmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlien","family":"Mul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dumonceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-7295","authenticated-orcid":false,"given":"Nicol","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gomez-Rodulfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u202f","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica\u202f","family":"Montagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"de Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lemmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dumonceaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Camano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke","family":"van der Stoep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Burton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Magdinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Race","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mejat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piraye","family":"Oflazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Guizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid","family":"Arjomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Pereon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Bugiardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Belayew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0001","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nmd.2023.04.005_bib0002","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.nmd.2021.07.013","article-title":"1st FSHD European trial network workshop:working towards trial readiness across Europe","volume":"31","author":"Voermans","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0003","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12883-019-1452-x","article-title":"Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study","volume":"19","author":"LoRusso","year":"2019","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0004","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"Tawil","year":"2015","journal-title":"Neurology"},{"issue":"5999","key":"10.1016\/j.nmd.2023.04.005_bib0005","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0006","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/mus.24247","article-title":"Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy","volume":"50","author":"Janssen","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mus.23911","article-title":"Longitudinal features of STIR bright signal in FSHD","volume":"49","author":"Friedman","year":"2014","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.nmd.2011.09.004","article-title":"Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: workshop 9th June 2010, LUMC, Leiden, The Netherlands","volume":"22","author":"Lemmers","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0009","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","article-title":"265th ENMC international workshop: muscle imaging in facioscapulohumeral muscular dystrophy (FSHD): relevance for clinical trials. 22-24 April 2022, Hoofddorp, The Netherlands","volume":"33","author":"Monforte","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"10.1016\/j.nmd.2023.04.005_bib0010","doi-asserted-by":"crossref","first-page":"e13695","DOI":"10.15252\/emmm.202013695","article-title":"Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7","volume":"13","author":"Banerji","year":"2021","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JND-210711","article-title":"Identification of serum interleukin 6 levels as a disease severity biomarker in facioscapulohumeral muscular dystrophy","volume":"9","author":"Gros","year":"2022","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2023.04.005_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113011","article-title":"Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy","volume":"320","author":"Mueller","year":"2019","journal-title":"Exp Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0013","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mus.25725","article-title":"Developing multidisciplinary clinics for neuromuscular care and research","volume":"56","author":"Paganoni","year":"2017","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0014","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.nmd.2017.09.007","article-title":"Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data","volume":"27","author":"Goselink","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.25326","article-title":"Facioscapulohumeral dystrophy in childhood: a nationwide natural history study","volume":"84","author":"Goselink","year":"2018","journal-title":"Ann Neurol"},{"issue":"21","key":"10.1016\/j.nmd.2023.04.005_bib0016","doi-asserted-by":"crossref","first-page":"e2103","DOI":"10.1212\/WNL.0000000000012882","article-title":"Natural history of facioscapulohumeral dystrophy in children: a 2-year follow-up","volume":"97","author":"Dijkstra","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0017","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1212\/WNL.0000000000011230","article-title":"Correlates of fatigability in patients with spinal muscular atrophy","volume":"96","author":"Bartels","year":"2021","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0018","first-page":"72","article-title":"Management of motor rehabilitation in individuals with muscular dystrophies. 1(st) consensus conference report from UILDM - Italian muscular dystrophy association (Rome, January 25-26, 2019)","volume":"40","author":"Lombardo","year":"2021","journal-title":"Acta Myol"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0019","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nmd.2010.04.007","article-title":"171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy","volume":"20","author":"Tawil","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0020","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1212\/01.WNL.0000150584.45055.27","article-title":"Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy","volume":"64","author":"Olsen","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0021","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1212\/01.WNL.0000134660.30793.1F","article-title":"Strength training and albuterol in facioscapulohumeral muscular dystrophy","volume":"63","author":"van der Kooi","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2023.04.005_bib0022","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2019.09.003","article-title":"Measurement properties and utility of performance-based outcome measures of physical functioning in individuals with facioscapulohumeral dystrophy - A systematic review and evidence synthesis","volume":"29","author":"de Valle","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1590\/2176-9451.19.6.037-045.oar","article-title":"Orthodontic treatment in a patient with unilateral open-bite and Becker muscular dystrophy. A 5-year follow-up","volume":"19","author":"Aristizabal","year":"2014","journal-title":"Dental Press J Orthod"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0024","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M","article-title":"Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype","volume":"45","author":"Ricci","year":"1999","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.nmd.2023.04.005_bib0025","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/13696998.2020.1797755","article-title":"Composite outcome measurement in clinical research: the triumph of illusion over reality?","volume":"23","author":"McKenna","year":"2020","journal-title":"J Med Econ"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0026","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nmd.2022.12.005","article-title":"Meeting report: the 2022 FSHD international research congress","volume":"33","author":"Leung","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0027","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mus.27123","article-title":"Motion sensor-acquired reachable workspace correlates with patient-reported upper extremity activities of daily living (ADL) function in facioscapulohumeral dystrophy","volume":"63","author":"Hatch","year":"2021","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0028","doi-asserted-by":"crossref","first-page":"e1180","DOI":"10.1212\/WNL.0000000000008123","article-title":"Patient-reported symptoms in facioscapulohumeral muscular dystrophy (PRISM-FSHD)","volume":"93","author":"Hamel","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0029","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1111\/ene.14863","article-title":"The facioscapulohumeral muscular dystrophy Rasch-built overall disability scale (FSHD-RODS)","volume":"28","author":"Mul","year":"2021","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.nmd.2023.04.005_bib0030","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1080\/09638288.2022.2066208","article-title":"Development and validation of the patient-reported \u201cFacial Function Scale\u201d for facioscapulohumeral muscular dystrophy","volume":"45","author":"Mul","year":"2023","journal-title":"Disabil Rehabil"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11071275","article-title":"Digital biomarkers for neuromuscular disorders: a systematic scoping review","volume":"11","author":"Youn","year":"2021","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0032","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000517411","article-title":"First regulatory qualification of a novel digital endpoint in duchenne muscular dystrophy: a multi-stakeholder perspective on the impact for patients and for drug development in neuromuscular diseases","volume":"5","author":"Servais","year":"2021","journal-title":"Digit Biomark"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0033","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mus.27446","article-title":"Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy","volume":"65","author":"Gidaro","year":"2022","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0034","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mus.26681","article-title":"A pilot study of the responsiveness of wireless motion analysis in facioscapulohumeral muscular dystrophy","volume":"60","author":"Statland","year":"2019","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s00415-016-8123-2","article-title":"A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes","volume":"263","author":"Ricci","year":"2016","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0036","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/geno.1994.1006","article-title":"Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions","volume":"19","author":"Wijmenga","year":"1994","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0037","first-page":"396","article-title":"Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium","volume":"51","author":"Sarfarazi","year":"1992","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0038","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","article-title":"FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit","volume":"2","author":"van Deutekom","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0039","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng999","article-title":"Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere","volume":"32","author":"Lemmers","year":"2002","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0040","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.10057","article-title":"Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis","volume":"50","author":"Lemmers","year":"2001","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0041","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmg.33.5.361","article-title":"Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD)","volume":"33","author":"Deidda","year":"1996","journal-title":"J Med Genet"},{"issue":"10","key":"10.1016\/j.nmd.2023.04.005_bib0042","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/humu.23304","article-title":"Molecular combing reveals complex 4q35 rearrangements in Facioscapulohumeral dystrophy","volume":"38","author":"Nguyen","year":"2017","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0043","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jmedgenet-2019-106078","article-title":"Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD)","volume":"57","author":"Dai","year":"2020","journal-title":"J Med Genet"},{"issue":"11","key":"10.1016\/j.nmd.2023.04.005_bib0044","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jmoldx.2021.07.021","article-title":"Validation of optical genome mapping for the molecular diagnosis of facioscapulohumeral muscular dystrophy","volume":"23","author":"Stence","year":"2021","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0045","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0046","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","article-title":"Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy","volume":"98","author":"van den Boogaard","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"23","key":"10.1016\/j.nmd.2023.04.005_bib0047","doi-asserted-by":"crossref","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","article-title":"Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy","volume":"94","author":"Hamanaka","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0048","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1053\/j.ajkd.2018.02.351","article-title":"Genetic testing in clinical settings","volume":"72","author":"Franceschini","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0049","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10048-019-00575-4","article-title":"Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era","volume":"20","author":"Zampatti","year":"2019","journal-title":"Neurogenetics"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cge.14031","article-title":"Facioscapulohumeral muscular dystrophy-reproductive counseling, pregnancy, and delivery in a complex multigenetic disease","volume":"101","author":"Vincenten","year":"2022","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0051","doi-asserted-by":"crossref","first-page":"E444","DOI":"10.1212\/WNL.0000000000005915","article-title":"A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1","volume":"91","author":"Wohlgemuth","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0052","first-page":"687","article-title":"Outcome measures in facioscapulohumeral muscular dystrophy","volume":"11","author":"Ghasemi","year":"2022","journal-title":"Clin Trials Cells"},{"issue":"5","key":"10.1016\/j.nmd.2023.04.005_bib0053","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4040","article-title":"Phenotypic variability among patients with D4Z4 reduced allele facioscapulohumeral muscular dystrophy","volume":"3","author":"Ruggiero","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.nmd.2023.04.005_bib0054","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ajhg.2010.01.035","article-title":"Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution","volume":"86","author":"Lemmers","year":"2010","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.nmd.2023.04.005_bib0055","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/ddu486","article-title":"Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2","volume":"24","author":"Lemmers","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2023.04.005_bib0056","series-title":"BEST (Biomarkers, Endpoints, and Other Tools) Resource","year":"2016"},{"issue":"5\u20136","key":"10.1016\/j.nmd.2023.04.005_bib0057","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/prca.201000130","article-title":"New pathway for qualification of novel methodologies in the European Medicines Agency","volume":"5","author":"Manolis","year":"2011","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.nmd.2023.04.005_bib0058","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13395-016-0078-6","article-title":"Neuromuscular electrical stimulation promotes development in mice of mature human muscle from immortalized human myoblasts","volume":"6","author":"Sakellariou","year":"2016","journal-title":"Skelet Muscle"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0059","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.devcel.2011.11.013","article-title":"DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy","volume":"22","author":"Geng","year":"2012","journal-title":"Dev Cell"},{"issue":"10","key":"10.1016\/j.nmd.2023.04.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001181","article-title":"Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene","volume":"6","author":"Snider","year":"2010","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0061","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192657","article-title":"A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy","volume":"13","author":"Jones","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0062","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13395-020-00227-4","article-title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity","volume":"10","author":"Jones","year":"2020","journal-title":"Skelet Muscle"},{"issue":"8","key":"10.1016\/j.nmd.2023.04.005_bib0063","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049016","article-title":"Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models","volume":"14","author":"Nunes","year":"2021","journal-title":"Dis Model Mech"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0064","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/jpm10040236","article-title":"Multi-omics identifies circulating miRNA and protein biomarkers for facioscapulohumeral dystrophy","volume":"10","author":"Heier","year":"2020","journal-title":"J Pers Med"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nmd.2022.03.003","article-title":"Serum miRNAs as biomarkers for the rare types of muscular dystrophy","volume":"32","author":"Koutsoulidou","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.nmd.2023.04.005_bib0066","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12199-014-0405-7","article-title":"Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy","volume":"19","author":"Matsuzaka","year":"2014","journal-title":"Environ Health Prev Med"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0067","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/ijms22010290","article-title":"Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy","volume":"22","author":"Corasolla Carregari","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0068","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.nmd.2016.04.012","article-title":"A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)","volume":"26","author":"Petek","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2023.04.005_bib0069","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/JND-140034","article-title":"Multiplex screen of serum biomarkers in facioscapulohumeral muscular dystrophy","volume":"1","author":"Statland","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"11","key":"10.1016\/j.nmd.2023.04.005_bib0070","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/hmg\/ddab364","article-title":"Elevated plasma complement components in facioscapulohumeral dystrophy","volume":"31","author":"Wong","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"46","key":"10.1016\/j.nmd.2023.04.005_bib0071","doi-asserted-by":"crossref","first-page":"18157","DOI":"10.1073\/pnas.0708659104","article-title":"DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1","volume":"104","author":"Dixit","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0072","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/humu.24171","article-title":"Relationship of DUX4 and target gene expression in FSHD myocytes","volume":"42","author":"Chau","year":"2021","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0073","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41467-017-01200-4","article-title":"PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle","volume":"8","author":"Banerji","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0074","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/1087057116651868","article-title":"Transcriptional inhibitors identified in a 160,000-compound small-molecule DUX4 viability screen","volume":"21","author":"Choi","year":"2016","journal-title":"J Biomol Screen"},{"issue":"20","key":"10.1016\/j.nmd.2023.04.005_bib0075","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1093\/hmg\/ddu251","article-title":"DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle","volume":"23","author":"Yao","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.nmd.2023.04.005_bib0076","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J"},{"key":"10.1016\/j.nmd.2023.04.005_bib0077","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad221","article-title":"A circulating biomarker of facioscapulohumeral muscular dystrophy clinical severity, valid in skeletal muscle and blood","author":"Banerji","year":"2023","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.nmd.2023.04.005_bib0078","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat Commun"},{"issue":"22","key":"10.1016\/j.nmd.2023.04.005_bib0079","doi-asserted-by":"crossref","first-page":"e123538","DOI":"10.1172\/jci.insight.123538","article-title":"AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD","volume":"3","author":"Giesige","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.nmd.2023.04.005_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.840074","article-title":"Editorial: lessons learned from translational research in neuromuscular diseases: impact on study design, outcome measures and managing expectation","volume":"13","author":"Mayhew","year":"2022","journal-title":"Front Genet"},{"issue":"7","key":"10.1016\/j.nmd.2023.04.005_bib0081","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/biomedicines10071623","article-title":"Long-term systemic treatment of a mouse model displaying chronic FSHD-like pathology with antisense therapeutics that inhibit DUX4 expression","volume":"10","author":"Lu-Nguyen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nmd.2023.04.005_bib0082","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.omtn.2021.09.010","article-title":"Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy","volume":"26","author":"Bouwman","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"17\u201318","key":"10.1016\/j.nmd.2023.04.005_bib0083","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/hum.2021.251","article-title":"Improving molecular and histopathology in diaphragm muscle of the double transgenic ACTA1-MCM\/FLExDUX4 mouse model of FSHD with systemic antisense therapy","volume":"33","author":"Lu-Nguyen","year":"2022","journal-title":"Hum Gene Ther"},{"issue":"15","key":"10.1016\/j.nmd.2023.04.005_bib0084","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/hmg\/ddab136","article-title":"Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model","volume":"30","author":"Lu-Nguyen","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1016\/j.nmd.2023.04.005_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JND-180318","article-title":"MRI-guided biopsy as a tool for diagnosis and research of muscle disorders","volume":"5","author":"Lassche","year":"2018","journal-title":"J Neuromuscul Dis"},{"issue":"4","key":"10.1016\/j.nmd.2023.04.005_bib0086","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00415-020-10281-z","article-title":"Characterizing the face in facioscapulohumeral muscular dystrophy","volume":"268","author":"Loonen","year":"2021","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.nmd.2023.04.005_bib0087","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1111\/ene.14446","article-title":"Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging","volume":"27","author":"Giacomucci","year":"2020","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.nmd.2023.04.005_bib0088","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nmd.2017.04.004","article-title":"225th ENMC international workshop: a global FSHD registry framework, 18-20 November 2016, Heemskerk, The Netherlands","volume":"27","author":"Mul","year":"2017","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896623001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:48Z","timestamp":1760775228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896623001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0960896623001025"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2023.04.005","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}